{"id":1576,"date":"2025-09-19T00:00:00","date_gmt":"2025-09-19T00:00:00","guid":{"rendered":"https:\/\/entrhal-medical.de\/en\/?p=1576"},"modified":"2025-09-17T05:13:49","modified_gmt":"2025-09-17T05:13:49","slug":"between-regulation-price-pressure-and-global-crises-our-daily-reality-as-a-medtech-company","status":"publish","type":"post","link":"https:\/\/entrhal-medical.de\/en\/between-regulation-price-pressure-and-global-crises-our-daily-reality-as-a-medtech-company\/","title":{"rendered":"Between Regulation, Price Pressure, and Global Crises \u2013 Our Daily Reality as a MedTech Company"},"content":{"rendered":"
\n

For many years, we at Entrhal have been developing, producing, and distributing innovative test devices and solutions for CSSD and patient safety. But the environment in which we operate has changed drastically in recent years \u2013 and certainly not for the better.<\/p>\n<\/div>\n\n

\n

The Challenge of the MDR<\/h2>\n<\/div>\n\n
\n

The introduction of the Medical Device Regulation (MDR)<\/strong> has become a major burden, especially for small and medium-sized enterprises. We feel this pressure every single day.<\/p>\n<\/div>\n\n

\n

The requirements are extremely high \u2013 from extensive documentation and complex certifications to regular audits.<\/strong> For a company of our size, this doesn\u2019t only mean a lot of extra work, but also significant costs<\/strong>. Money we would much rather invest in research, development, and product improvements is instead tied up in bureaucracy.<\/p>\n<\/div>\n\n

\n

On top of that, the MDR consumes our human resources<\/strong>. Team members who could otherwise dedicate their time to projects, product development, or customer support now need to handle regulatory tasks. For a small team like ours, this is a huge challenge.<\/p>\n<\/div>\n\n

\n

Price Pressure in german Hospitals \u2013 Especially for Single-Use Instruments<\/h2>\n<\/div>\n\n
\n

At the same time, we see the struggles german hospitals are facing:<\/p>\n<\/div>\n\n

\n

Many facilities are under financial stress, dealing with budget cuts, staff shortages, and rising operating costs<\/strong>. These conditions \u2013 shaped by political decisions and economic constraints \u2013 put hospitals under increasing pressure, and in turn, affect their partners.<\/p>\n<\/div>\n\n

\n

We notice this most clearly with our Clinastar single-use instruments<\/strong>. Hospitals are often forced to decide based primarily on the lowest price. Understandably so, when budgets are tight \u2013 but this makes it difficult to truly recognize the value of quality, reliability, and patient safety<\/strong>.<\/p>\n<\/div>\n\n

\n

We know our customers are dealing with the same challenges as we are. That\u2019s why it\u2019s so important to us to find solutions together that are both economically viable and put safety in the OR first.<\/strong><\/p>\n<\/div>\n\n

\n

A Big Market \u2013 Yet Difficult<\/h2>\n<\/div>\n\n
\n

Germany<\/strong> is one of the largest and most important MedTech markets<\/strong> in Europe. In theory, this should provide a stable foundation for growth and innovation. But the combination of MDR-related costs<\/strong>, price pressure \u2013 especially in the single-use segment \u2013 and global economic uncertainty makes it increasingly difficult<\/strong> for smaller companies to unlock their potential here.<\/p>\n<\/div>\n\n

\n

Economy in Crisis Mode<\/h2>\n<\/div>\n\n
\n

On top of that, recent global crises have made things worse:<\/p>\n<\/div>\n\n

\n